Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Gracell Biotechnologies Inc. (GRCL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.5300-0.0100 (-0.39%)
At close: 04:00PM EDT
2.5300 0.00 (0.00%)
After hours: 04:02PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

Currency in CNY. All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
366
366
0
0
0
Operating Expense
576,608
463,939
214,396
146,580
62,504
Operating Income
-576,242
-463,573
-214,396
-146,580
-62,504
Net Non Operating Interest Income Expense
6,150
4,053
715
3,932
1,435
Other Income Expense
7,334
7,766
1,781
3,984
276
Pretax Income
-562,758
-451,754
-211,900
-138,664
-60,793
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-562,758
-453,743
-274,633
-138,664
-72,992
Diluted NI Available to Com Stockholders
-562,758
-453,743
-274,633
-138,664
-72,992
Basic EPS
-
-6.90
-13.85
-3.75
-3.68
Diluted EPS
-
-6.90
-13.85
-3.75
-3.68
Basic Average Shares
-
65,773
19,809
36,967
19,809
Diluted Average Shares
-
65,773
19,809
36,967
19,809
Total Operating Income as Reported
-576,242
-463,573
-214,396
-146,580
-62,504
Total Expenses
576,608
463,939
214,396
146,580
62,504
Net Income from Continuing & Discontinued Operation
-562,758
-451,754
-211,900
-138,664
-60,793
Normalized Income
-559,167
-450,457
-208,986
-141,220
-60,793
Interest Income
11,648
9,116
2,870
3,932
1,435
Interest Expense
5,498
5,063
2,155
-
0
Net Interest Income
6,150
4,053
715
3,932
1,435
EBIT
-557,260
-446,691
-209,745
-146,580
-60,793
EBITDA
-480,502
-
-
-
-
Reconciled Depreciation
76,758
60,267
21,589
5,124
2,992
Net Income from Continuing Operation Net Minority Interest
-562,758
-451,754
-211,900
-138,664
-60,793
Total Unusual Items Excluding Goodwill
-3,591
-1,297
-2,914
2,556
-
Total Unusual Items
-3,591
-1,297
-2,914
2,556
-
Normalized EBITDA
-476,911
-385,127
-185,242
-144,012
-57,801
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement